Need the medicines! No access? Take action! Eva M A Ombaka Member, Health Action International Dar es Salaam, Tanzania.

Slides:



Advertisements
Similar presentations
1 The role of NEPAD in improving quality and effectiveness of aid for Agricultural development Amadou Allahoury Diallo Senior Water Specialist NEPAD.
Advertisements

Role of CSOs in monitoring Policies and Progress on MDGs.
The Danish Civil Society Strategy – reflecting past experience while embracing new approaches? 16 June 2009 Lars Udsholt.
Community based HIV treatment COBASYS WORKPLAN 3 REACH Trust.
What Is Civil Society  Neither private sector (for profit) nor government  Presents a powerful respectful image  Can assist in providing policy makers.
INTERNATIONAL UNION FOR CONSERVATION OF NATURE. 2 Implemented in 12 countries of Africa, Asia, Latin America and the Middle East, through IUCN regional.
Zambian Civil Society Organizations, TRIPS and Access to Medicines Zambia Civil Society Consultation Meeting 1 st October 2013 Daniel S. Libati, LLB (UNZA)
Consensus Building Workshop for an Advocacy Strategy on Population Issues in Lebanon 3 – 4 April 2006 Experiences in Advocacy: Presented by: Ms. Seta Hadeshian.
RARE ACTION NETWORK ® Presentation by NORD June 16, 2014.
Energising & Empowering Civil Society Engagement with Public Budgets and Expenditure in Southern Africa Centre for Economic Governance and AIDS in Africa.
ECONOMY OF GHANA NETWORK IMPLICATION OF RTI LAW ON GOOD GOVERNANCE AND TRANSPARENCY & ACCOUNTABILITY BY FLORENCE DENNIS GHANA ANTI-CORRUPTION COALITION.
The informed citizen: a new partner in the political health arena? 1 The advocacy activity of the Italian Tribunal for patient’s rights Teresa Petrangolini.
AVOID A CHRONIC PAIN AS A PATIENTS’ RIGHT Teresa Petrangolini Active Citizenship Network - PAE.
UNESCO ’ s CCNGO/EFA Outcomes from the Annual Assembly in Porto Alegre.
Role of the community/volunteers in the delivery of the TB/HIV package: David Coetzee February 2005 UNIVERSITY OF CAPE TOWN School of Public Health and.
1 Workshop on social inclusion of disabled people, Sofia, October 2006 DISABILITY ORGANISATIONS Luk Zelderloo, EASPD.
July, – UNESCO Paris Fifth Meeting of the EFA Working Group Civil society engagement in EFA after Dakar: What has been the value added?
Bond.org.uk The Bond Effectiveness Programme: developing a sector wide framework for assessing and demonstrating effectiveness July 2011.
OPTIONS AND REQUIREMENTS FOR ENGAGEMENT OF CIVIL SOCIETY IN GEF PROJECTS AND PROGRAMMES presented by Faizal Parish Regional/Central Focal Point GEF NGO.
Vision: Sustainable development for Cambodia.  Status of civil society  Internal and external demands  Contributions of CCC members to development.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
TB/HIV COMMUNITY MOBILIZATION IN AFRICA: Ongoing activities, achievements and challenges Paula Akugizibwe, AIDS and Rights Alliance for Southern AFrica.
NGO Management Lesson 3 NGO Strategy
Lobbying Techniques and the Southern African Experience Presented by Yvonne Chibiya Human Rights and Development Trust of Southern Africa (HURIDETSA)
Pharmacy Administration By Dr. Shaimaa Mahmoud Nashat Canadian equivalent Master Degree in Clinical Pharmacy - Toronto University – Canada Canadian Board.
The importance of Research Quality from the Perspective of CSOs By Princess O. Ifode Programme Officer Intervention Council for Women in Africa (ICWA)
BACKGROUND NOTE FOR THE NATIONAL ADVOCACY AND TRAINING WORKSHOPS IN KENYA, UGANDA, TANZANIA, BURUNDI AND RWANDA ON ACCELERATING THE IMPLEMENTATION OF EAC.
A vision statement tells the type of community or world the organization envisions for its constituency as a result of the work of the organization.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Country Ownership of National HIV & AIDS Response: A Private Sector Perspective Country Ownership of National HIV & AIDS Response: A Private Sector Perspective.
About Social Watch Social Watch, III General Assembly.
1 WORKSHOP SUMMARY Nguyễn mạnh Cường, PhD 2 October 2007.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
1 Introduction and Basic Elements of Advocacy. 2 What is advocacy? A systematic approach to changing policies and programs to reflect the needs of individuals.
June 2009 World Hospice and Palliative Care Day Discovering your voice.
Pricing and the Pharmaceutical Industry What’s Realistic? What’s Smart? What’s Right?
Regionalisation in Southern Africa: The SADC Principles and Guidelines and 2005 Zimbabwe Elections.
Overview of Advocacy, Communication, and Social Mobilization.
Zimbabwe CSOs TRIPS and Access to medicines Aulline Mabika-Chapisa.
CCIH ANNUAL CONFERENCE May 26-28, 2007 Presentation by Dr S. Mwenda EPN Ecumenical Pharmaceutical Network Réseau Pharmaceutique Œcuménique.
Stop the Stock-outs! Civil Society approaches to monitoring PSM for essential medicines Christa Cepuch BSc Phm Health Action International (HAI) Africa.
The League of Women Voters Join over 150,000 members and supporters across the country who are doing the hands-on work to safeguard democracy! League of.
Global Partnership on Disability and Development What is the GPDD? Presentation to JICA Group Training Course HIV/AIDS Section Judith Heumann, Lead Consultant,
ENVIRONMENTAL CITIZENSHIP NONGOVERNMENTAL ORGANIZATIONS.
7 CHAPTER.
Pricing and the Pharmaceutical Industry What’s Realistic? What’s Smart? What’s Right?
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Health challenges in an enlarged Europe Report from Parallel Session A1 Dr. Natasha Azzopardi Muscat Ministry of Health - Malta.
Global Campaign Against Brain Drain IPHU Short Course Savar, Bangladesh.
Washington D.C., USA, July 2012www.aids2012.org Treatment Monitoring & Advocacy Project: “Missing the Target Report Series” Othoman Mellouk ITPC-NA/ALCS.
WHO support to countries in the area of medicines example of the African Region WHO/EDM Drug Action Programme.
TB Public Private Partnerships Opportunity or Risk? Cheri Vincent Senior Public Health Advisor USAID June 3, 2008.
Unit 3 Influencing Government. 1.Influencing Government through our Political Parties  Contact your MP  Run for MP  Volunteer for a political party.
European Public Health Alliance Lobbying, the role of NGOs and communication strategies Tamsin Rose Sofia, 29 October 2005.
OPTIONS AND REQUIREMENTS FOR ENGAGEMENT OF CIVIL SOCIETY IN GEF PROJECTS presented by Ermath Harrington GEF Regional Focal Point.
NGOs & Transboundary Water Management “It is certain that the energy, experience, and commitment of NGOs are a great asset for policy making if the social.
Stop the Stock-outs! Access to Essential Medicines for All Christa Cepuch BSc Phm Health Action International Africa RHS Coalition Meeting 27 May 2010,
Medicines Transparency Alliance18/12/ Country overview MeTA Kyrgyzstan Mariam Djankorozova MeTA Country coordinator.
1/28/2016 Prevention Research and Natioanl Aids Plans Geneva 1 Prevention Research and National AIDS Plans June 2005 Geneva, Switzerland Prof. Roy.
1 Rights in Action Good practices for inclusive local governance in West Africa Benin, Burkina, Faso, Mali, Niger, Senegal, Sierra Leone, Togo Side event.
European Public Health Alliance Advocating for Better Health in the EU Lara Garrido-Herrero (ANME General Assembly) Frankfurt, 11 November 2006.
Partnerships Came up at the SGA. Mini meeting Current situation Why its an issue We need your input.
1 CIVIL SOCIETY AND CORPORATE SOCIAL RESPONSIBILITY IN VIETNAM: BRIDGING THE GAP Hanoi, March 2013.
About ARASA  ARASA is a regional partnership of 63 grassroots, national and regional non-governmental organisations working together to promote rights-based.
MeTA Phase I: Where are we? MeTA18/06/ MeTA2 The MeTA Phase I Proposal Purpose To pilot a new multi-stakeholder approach towards increasing transparency.
UHC 2030 CSO engagement mechanism Bruno Rivalan IHP+ Northern CSO Representative IHP+ Steering committee 21 th June 2016.
TRADE NEGOTIATION ON PHARMACETICALS PRESENTED BY CHOGO,MALESO (092SIS10).
What is an NGO.
Stop Stock-outs Campaign in Uganda
Strengthening Trade Union Global Action on HIV/AIDS
Presentation transcript:

Need the medicines! No access? Take action! Eva M A Ombaka Member, Health Action International Dar es Salaam, Tanzania

Medicines are essential part of life Cannot leave health/medicines needs (esp. developing countries and the poor) to profit - seeking industry. Put public health before profit Say no to a system that is not working!

Increasing access to medicines Six C's are needed (Devi Sridhar): Coalitions, Civil society, Citizenship, Compromise, Communication and Collaboration.

Increasing access to medicines First: developing countries must form a coalition that comes together to achieve a very specific objective and does not fragment. Unequal power between drug companies and many developing countries E.g. NEPAD; Doha, Regional communities

Increasing access to medicines Second: CSOs committed to health issues must continue to push the issue onto the political agenda. E.g. CSOs playing a role in research-provide data Activists can campaign e.g. loud support for the implementation of the TRIPS safeguards Undertake advocacy work with policy makers and funders Be part of agenda setting

Increasing access to medicines Third: citizens in developed countries need to pressure their governments to prioritize health concerns through lobbying, protesting and supporting CSOs e.g. Health Gap Act Up Paris

Increasing access to medicines Fourth: the various stakeholders must compromise to a certain extent so that progress can be made e.g. HAI/WHO pricing study MeTA IGWIG

Increasing access to medicines Fifth: health activists must communicate to the media, so that the media can frame the issue of access to essential medicines in an appealing manner. Collect information at grassroots Document, document, document!! Publish research findings

Increasing access to medicines Sixth: developing countries, CSOs and citizens in developed and developing countries must collaborate to ensure that the barriers to access to essential medicines are overcome. Kenya coalition on access to medicines TAC in South Africa

Increasing access to medicines- individual actions Be a resource! Skills Profession Time Financial In-kind

Increasing access to medicines- individual actions Use medicines carefully, rationally-it’s a precious resource Be informed-local situation, international situation Have a moral compass-not lose your independence individually or in groups Support alternative sources and life styles

Pharmacy? Grocery store? Trained? Expired? Rational?...

Increasing access to medicines- individual actions Join others e.g. Non-Governmental Organizations (NGO) Community-Based Organizations (CBO) Faith-based organizations e.g. YM/W/CA, Ramakrishna Mission etc Voluntary (patient) health organizations Networks/Movements e.g. PHM; HAI – in Africa, Asia/Pacific, Latin America, Europe; EPN; ReAct; etc etc

Get involved.....Thank you!